168 related articles for article (PubMed ID: 8140330)
1. [Capsular polysaccharide of Klebsiella pneumoniae. II. Immunogenic properties].
Alcántar-Curiel MD; Martínez-Ramos A; García-Latorre E
Rev Latinoam Microbiol; 1993; 35(1):109-15. PubMed ID: 8140330
[TBL] [Abstract][Full Text] [Related]
2. Targeting subcapsular antigens for prevention of Klebsiella pneumoniae infections.
Clements A; Jenney AW; Farn JL; Brown LE; Deliyannis G; Hartland EL; Pearse MJ; Maloney MB; Wesselingh SL; Wijburg OL; Strugnell RA
Vaccine; 2008 Oct; 26(44):5649-53. PubMed ID: 18725260
[TBL] [Abstract][Full Text] [Related]
3. Anti-capsular polysaccharide antibody deficiency states.
Rijkers GT; Sanders LA; Zegers BJ
Immunodeficiency; 1993; 5(1):1-21. PubMed ID: 8167745
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli and Klebsiella vaccines and immunotherapy.
Cross AS; Sadoff JC; Furer E; Cryz SJ
Infect Dis Clin North Am; 1990 Jun; 4(2):271-82. PubMed ID: 2189000
[TBL] [Abstract][Full Text] [Related]
5. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
6. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
7. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
8. Development of immunization trials against Klebsiella pneumoniae.
Ahmad TA; El-Sayed LH; Haroun M; Hussein AA; El Ashry el SH
Vaccine; 2012 Mar; 30(14):2411-20. PubMed ID: 22100884
[TBL] [Abstract][Full Text] [Related]
9. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy.
Fung CP; Hu BS; Chang FY; Lee SC; Kuo BI; Ho M; Siu LK; Liu CY
J Infect Dis; 2000 Jun; 181(6):2075-9. PubMed ID: 10837197
[TBL] [Abstract][Full Text] [Related]
10. Passive immunization of mice against Klebsiella aerogenes.
Roe EA; Jones RJ; Dyster RE
Br J Exp Pathol; 1986 Feb; 67(1):25-32. PubMed ID: 3511939
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.
Robert A; Jouin H; Fournier JM
Infect Immun; 1986 Nov; 54(2):365-70. PubMed ID: 3095240
[TBL] [Abstract][Full Text] [Related]
12. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis.
Stone MA; Payne U; Schentag C; Rahman P; Pacheco-Tena C; Inman RD
Rheumatology (Oxford); 2004 Feb; 43(2):148-55. PubMed ID: 12949256
[TBL] [Abstract][Full Text] [Related]
13. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model.
Lawlor MS; Hsu J; Rick PD; Miller VL
Mol Microbiol; 2005 Nov; 58(4):1054-73. PubMed ID: 16262790
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
[TBL] [Abstract][Full Text] [Related]
15. Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
Cryz SJ; Fürer E; Germanier R
J Infect Dis; 1984 Dec; 150(6):817-22. PubMed ID: 6389718
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of Klebsiella pneumoniae infections in 2 colonies of squirrel monkeys and lemurs].
Richard C
Bull Soc Pathol Exot Filiales; 1989; 82(4):458-64. PubMed ID: 2680130
[TBL] [Abstract][Full Text] [Related]
17. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae.
Kobayashi SD; DeLeo FR
Future Microbiol; 2018 Sep; 13(12):1343-1346. PubMed ID: 30256152
[No Abstract] [Full Text] [Related]
18. Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.
Diago-Navarro E; Calatayud-Baselga I; Sun D; Khairallah C; Mann I; Ulacia-Hernando A; Sheridan B; Shi M; Fries BC
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795303
[TBL] [Abstract][Full Text] [Related]
19. Immunoprotective potential of polysaccharide-tetanus toxoid conjugate in Klebsiella pneumoniae induced lobar pneumonia in rats.
Chhibber S; Rani M; Vanashree Y
Indian J Exp Biol; 2005 Jan; 43(1):40-5. PubMed ID: 15691064
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity.
Lee WH; Choi HI; Hong SW; Kim KS; Gho YS; Jeon SG
Exp Mol Med; 2015 Sep; 47(9):e183. PubMed ID: 26358222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
